India city Mumbai city Delhi city Hyderabad covid-19 vaccine India city Mumbai city Delhi city Hyderabad

India’s framework has a specific provision for granting EUA: Official on Covid vaccines

Reading now: 878
www.livemint.com

Bharat Biotech had on Monday applied to the central drug regulator seeking emergency use authorisation for its COVID-19 vaccine Covaxin.Covaxin is being indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).The Hyderabad-based firm is conducting phase-3 clinical trial of its vaccine in around 25 places, including Delhi, Mumbai, Patna and Lucknow.The firm, while applying for the phase-3 trial, had stated that the vaccine was well-tolerated in all dose groups and no serious adverse events have been reported.Bhushan also said that Drugs Controller General of India could grant a license to some developers of Covid-19 vaccines in the next few weeks.Six vaccines, including AstraZeneca's.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA